Logo image of ERA.PA

ERAMET (ERA.PA) Stock Fundamental Analysis

Europe - EPA:ERA - FR0000131757 - Common Stock

59.325 EUR
-0.27 (-0.46%)
Last: 10/22/2025, 5:29:46 PM
Fundamental Rating

3

Taking everything into account, ERA scores 3 out of 10 in our fundamental rating. ERA was compared to 43 industry peers in the Metals & Mining industry. ERA has a bad profitability rating. Also its financial health evaluation is rather negative. ERA is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

ERA had negative earnings in the past year.
ERA had a negative operating cash flow in the past year.
Of the past 5 years ERA 4 years were profitable.
ERA had a positive operating cash flow in 4 of the past 5 years.
ERA.PA Yearly Net Income VS EBIT VS OCF VS FCFERA.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M 1B

1.2 Ratios

ERA has a Return On Assets of -1.58%. This is in the lower half of the industry: ERA underperforms 62.79% of its industry peers.
ERA has a worse Return On Equity (-9.29%) than 67.44% of its industry peers.
ERA's Return On Invested Capital of 0.84% is on the low side compared to the rest of the industry. ERA is outperformed by 67.44% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ERA is in line with the industry average of 8.00%.
The 3 year average ROIC (7.61%) for ERA is well above the current ROIC(0.84%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROIC 0.84%
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ERA.PA Yearly ROA, ROE, ROICERA.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 -60 -80

1.3 Margins

ERA's Profit Margin has declined in the last couple of years.
Looking at the Operating Margin, with a value of 1.91%, ERA is doing worse than 67.44% of the companies in the same industry.
ERA's Operating Margin has declined in the last couple of years.
With an excellent Gross Margin value of 68.15%, ERA belongs to the best of the industry, outperforming 93.02% of the companies in the same industry.
In the last couple of years the Gross Margin of ERA has grown nicely.
Industry RankSector Rank
OM 1.91%
PM (TTM) N/A
GM 68.15%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
ERA.PA Yearly Profit, Operating, Gross MarginsERA.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

More info and screens

2

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ERA is destroying value.
Compared to 1 year ago, ERA has more shares outstanding
Compared to 5 years ago, ERA has more shares outstanding
The debt/assets ratio for ERA has been reduced compared to a year ago.
ERA.PA Yearly Shares OutstandingERA.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
ERA.PA Yearly Total Debt VS Total AssetsERA.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

Based on the Altman-Z score of 1.11, we must say that ERA is in the distress zone and has some risk of bankruptcy.
ERA has a Altman-Z score of 1.11. This is in the lower half of the industry: ERA underperforms 76.74% of its industry peers.
ERA has a Debt/Equity ratio of 2.03. This is a high value indicating a heavy dependency on external financing.
ERA's Debt to Equity ratio of 2.03 is on the low side compared to the rest of the industry. ERA is outperformed by 86.05% of its industry peers.
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Altman-Z 1.11
ROIC/WACC0.09
WACC9.36%
ERA.PA Yearly LT Debt VS Equity VS FCFERA.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B

2.3 Liquidity

ERA has a Current Ratio of 1.54. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
ERA has a Current ratio of 1.54. This is in the lower half of the industry: ERA underperforms 65.12% of its industry peers.
ERA has a Quick Ratio of 1.06. This is a normal value and indicates that ERA is financially healthy and should not expect problems in meeting its short term obligations.
ERA has a Quick ratio of 1.06. This is comparable to the rest of the industry: ERA outperforms 51.16% of its industry peers.
Industry RankSector Rank
Current Ratio 1.54
Quick Ratio 1.06
ERA.PA Yearly Current Assets VS Current LiabilitesERA.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

4

3. Growth

3.1 Past

ERA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -221.18%.
Measured over the past years, ERA shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -64.00% on average per year.
The Revenue has decreased by -6.91% in the past year.
Measured over the past years, ERA shows a decrease in Revenue. The Revenue has been decreasing by -4.39% on average per year.
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%

3.2 Future

The Earnings Per Share is expected to grow by 10.10% on average over the next years. This is quite good.
ERA is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 8.46% yearly.
EPS Next Y-283.87%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
EPS Next 5YN/A
Revenue Next Year6.09%
Revenue Next 2Y7.62%
Revenue Next 3Y8.46%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ERA.PA Yearly Revenue VS EstimatesERA.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ERA.PA Yearly EPS VS EstimatesERA.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 10 20 30

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ERA. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 8.66 indicates a reasonable valuation of ERA.
86.05% of the companies in the same industry are more expensive than ERA, based on the Price/Forward Earnings ratio.
ERA's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 23.23.
Industry RankSector Rank
PE N/A
Fwd PE 8.66
ERA.PA Price Earnings VS Forward Price EarningsERA.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 30

4.2 Price Multiples

ERA's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 15.68
ERA.PA Per share dataERA.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 -20 40 60 80 100

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y27.79%
EPS Next 3Y10.1%

More info and screens

2

5. Dividend

5.1 Amount

ERA has a Yearly Dividend Yield of 2.13%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.51, ERA pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.36, ERA has a dividend comparable with the average S&P500 company.
Industry RankSector Rank
Dividend Yield 2.13%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years1
ERA.PA Yearly Dividends per shareERA.PA Yearly Dividends per shareYearly Dividends per share 2019 2022 2023 2024 2025 1 2 3

5.3 Sustainability

ERA has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-44.33%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
ERA.PA Yearly Income VS Free CF VS DividendERA.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M -500M

More info and screens

ERAMET

EPA:ERA (10/22/2025, 5:29:46 PM)

59.325

-0.27 (-0.46%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)07-30 2025-07-30
Earnings (Next)10-30 2025-10-30
Inst Owners12.66%
Inst Owner ChangeN/A
Ins Owners0.17%
Ins Owner ChangeN/A
Market Cap1.71B
Revenue(TTM)2.88B
Net Income(TTM)-97000000
Analysts52.73
Price Target52.22 (-11.98%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 2.13%
Yearly Dividend1.51
Dividend Growth(5Y)N/A
DP-44.33%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.92%
PT rev (3m)-14.43%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-535.33%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.03%
Revenue NY rev (3m)0.69%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 8.66
P/S 0.59
P/FCF N/A
P/OCF N/A
P/B 1.63
P/tB 3.16
EV/EBITDA 15.68
EPS(TTM)-3.44
EYN/A
EPS(NY)6.85
Fwd EY11.55%
FCF(TTM)-25.76
FCFYN/A
OCF(TTM)-4.59
OCFYN/A
SpS100.31
BVpS36.3
TBVpS18.78
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1.58%
ROE -9.29%
ROCE 1.16%
ROIC 0.84%
ROICexc 0.99%
ROICexgc 1.13%
OM 1.91%
PM (TTM) N/A
GM 68.15%
FCFM N/A
ROA(3y)4.1%
ROA(5y)1.33%
ROE(3y)16.44%
ROE(5y)-1.91%
ROIC(3y)7.61%
ROIC(5y)8.07%
ROICexc(3y)11.46%
ROICexc(5y)11.88%
ROICexgc(3y)13.48%
ROICexgc(5y)14.02%
ROCE(3y)10.76%
ROCE(5y)11.32%
ROICexgc growth 3Y-56.22%
ROICexgc growth 5Y-25.38%
ROICexc growth 3Y-55.33%
ROICexc growth 5Y-24.94%
OM growth 3Y-46.5%
OM growth 5Y-18.83%
PM growth 3Y-61.12%
PM growth 5YN/A
GM growth 3Y-3.21%
GM growth 5Y23.96%
F-Score2
Asset Turnover0.47
Health
Industry RankSector Rank
Debt/Equity 2.03
Debt/FCF N/A
Debt/EBITDA 10.29
Cap/Depr 403.31%
Cap/Sales 21.11%
Interest Coverage 0.34
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.54
Quick Ratio 1.06
Altman-Z 1.11
F-Score2
WACC9.36%
ROIC/WACC0.09
Cap/Depr(3y)260.42%
Cap/Depr(5y)209.27%
Cap/Sales(3y)18.57%
Cap/Sales(5y)15.29%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-221.18%
EPS 3Y-64%
EPS 5YN/A
EPS Q2Q%-268.75%
EPS Next Y-283.87%
EPS Next 2Y27.79%
EPS Next 3Y10.1%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.91%
Revenue growth 3Y-7.18%
Revenue growth 5Y-4.39%
Sales Q2Q%-3.31%
Revenue Next Year6.09%
Revenue Next 2Y7.62%
Revenue Next 3Y8.46%
Revenue Next 5YN/A
EBIT growth 1Y-51.75%
EBIT growth 3Y-50.34%
EBIT growth 5Y-22.39%
EBIT Next Year19.46%
EBIT Next 3Y25.5%
EBIT Next 5YN/A
FCF growth 1Y-850%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-121.46%
OCF growth 3YN/A
OCF growth 5YN/A